Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 24
Filtrar
1.
Pediatr Dermatol ; 40(6): 1094-1096, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-36973173

RESUMEN

Tricho-dento-osseous syndrome (TDOS) is a rare ectodermal dysplasia caused by mutations in the DLX3 gene and it is not usually included as a cause of syndromic woolly hair. We present a new case of TDOS with a novel DLX3 variant and woolly hair.


Asunto(s)
Enfermedades del Cabello , Factores de Transcripción , Humanos , Factores de Transcripción/genética , Proteínas de Homeodominio/genética , Enfermedades del Cabello/diagnóstico , Enfermedades del Cabello/genética , Cabello
2.
Lasers Surg Med ; 54(6): 823-824, 2022 08.
Artículo en Inglés | MEDLINE | ID: mdl-35485783

RESUMEN

We present the case of a 16-year-old boy with Peutz-Jeghers disease with successful treatment of oral lentiginosis with one session of picosecond 755-nm alexandrite laser. To date, only in one other article picosecond laser is used for lentiginosis in Peutz-Jeghers disease. Other therapeutical options include Q-switched 755-nm alexandrite, 1064-nm Nd:YAG, 532-nm KTP-laser, ruby and intense pulsed light, which generally require more sessions, are less pigment-selective and have overall worse results than picosecond laser treatment.


Asunto(s)
Terapia por Láser , Láseres de Estado Sólido , Lentigo , Síndrome de Peutz-Jeghers , Adolescente , Berilio , Humanos , Terapia por Láser/métodos , Láseres de Estado Sólido/uso terapéutico , Lentigo/etiología , Lentigo/radioterapia , Lentigo/cirugía , Masculino , Síndrome de Peutz-Jeghers/complicaciones , Síndrome de Peutz-Jeghers/radioterapia , Síndrome de Peutz-Jeghers/cirugía , Resultado del Tratamiento
17.
Skinmed ; 21(3): 200-202, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37634107

RESUMEN

A 91-year-old man presented with pruriginous tense blisters and erosions on the upper and lower extremities (Figures 1A and 1B). Mucous membranes were unaffected and Nikolsky's sign was negative. These lesions appeared 48 hours after the administration of the second dose of the Pfizer-BioNTech COVID-19 vaccine. The patient had received the first dose of the same vaccine 23 days prior to the onset of lesions. He did not suffer from any other post-vaccination adverse effects.


Asunto(s)
COVID-19 , Penfigoide Ampolloso , Masculino , Humanos , Anciano de 80 o más Años , Vacunas contra la COVID-19/efectos adversos , Vacuna BNT162 , Penfigoide Ampolloso/etiología , COVID-19/prevención & control , Vesícula
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA